S. 4703

S. 4703: A bill to prohibit Federal funds from being used for certain legal financial settlements, and for other purposes.

Introduced Jacky Rosen (D) SENATE_BILL — 119th Congress
Plain English Summary

S. 4703 is a bill aimed at prohibiting the use of federal funds for specific legal financial settlements. This suggests that the bill seeks to restrict how federal money can be allocated in cases involving legal settlements, potentially targeting issues like settlements that may not align with federal interests or policies.

Positive Media Summary

Supporters of S. 4703 argue that the bill promotes accountability and ensures that taxpayer money is not used to fund settlements that may be seen as unjust or inappropriate. Advocates believe it will deter misuse of federal funds and protect public resources.

Negative Media Summary

Critics of S. 4703 contend that the bill could hinder the ability of individuals and entities to seek justice through legal settlements. They argue that it may limit the effectiveness of legal recourse and could disproportionately affect those who rely on settlements to resolve disputes, raising concerns about access to justice.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

While there are no direct industry overlaps between the sponsor's top donor industries and the subject matter of Bill S. 4703, there are significant lobbying activities related to legal financial settlements. Notably, the American College of Clinical Pharmacy has contributed $144,981, which could suggest an interest in healthcare-related legal settlements. Additionally, Altria Client Services, a major player in the tobacco industry, has contributed $40,000, raising questions about potential influences on legislation that could affect financial settlements related to health issues. The presence of multiple undisclosed contributions from organizations like the National Sleep Foundation and Sleep, Inc. further complicates the transparency of interests involved. Voters should be aware of these connections as they may indicate underlying motivations for supporting this bill.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
AMERICAN COLLEGE OF CLINICAL PHARMACY AMERICAN COLLEGE OF CLINICAL PHARMACY $144,981
PERSISTENT SYSTEMS, LLC PERSISTENT SYSTEMS, LLC $60,000
ALTRIA CLIENT SERVICES MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) $40,000
CROHN'S & COLITIS FOUNDATION CROHN'S & COLITIS FOUNDATION $40,000
GOTRIANGLE MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) $30,000
AFRICAN AMERICAN ALLIANCE OF CDFI CEOS MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) $20,000
CITY OF GLADEWATER, TEXAS LONE STAR CONSULTING, LLC $12,000
CITY OF CRANDALL, TEXAS LONE STAR CONSULTING, LLC $10,000
NATIONAL SLEEP FOUNDATION SLEEP, INC. undisclosed
SLEEP, INC. SLEEP, INC. undisclosed
THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES MAGILL ASSOCIATES, LLC undisclosed
OPPORTUNITIES INDUSTRIALIZATION CENTER OF AMERICA, INC. MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) undisclosed
LUMBEE TRIBE HOLDINGS, INC. MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) undisclosed
CITY OF CLEVELAND, TEXAS LONE STAR CONSULTING, LLC undisclosed
CITY OF RIO HONDO, TEXAS LONE STAR CONSULTING, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Jacky Rosen, ranked by total contributions.

Health Professionals $640,000,000
Individuals: $640,000,000 PACs: $0
Retired $200,000,000
Individuals: $200,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us